SOPHiA GENETICS SA (SOPH)
| Previous close | 4.5400 |
| Open | 4.5900 |
| Bid | 4.4700 x 100 |
| Ask | 4.7000 x 100 |
| Day's range | 4.4400 - 4.6900 |
| 52-week range | 2.1300 - 7.3700 |
| Volume | |
| Avg. volume | 75,111 |
| Market cap | 297.457M |
| Beta (5Y monthly) | 1.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2200 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.67 |
PR NewswireSOPHiA GENETICS Announces Instituto Mário Penna as New Customer
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live on the SOPHiA DDM™ Platform. Located in Belo Horizonte, Brazil, the Instituto Mário Penna will use SOPHiA GENETICS' technology to advance its testing, research, and advance data-driven diagnoses and treatment decisions for blood-related cancers and disorders.
- PR Newswire
Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am Wörthersee, the third largest hospital in Austria, is live on the SOPHiA DDM™ Platform. The hospital will use SOPHiA GENETICS' technology to enhance its next-generation sequencing (NGS) testing and deepen its analytical capabilities for solid tumor and blood cancer (hematology oncology) samples.
Insider MonkeySOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript
SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript May 12, 2024 SOPHiA GENETICS SA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day everyone. My name is Jamie and I’ll be your conference operator today. At this time, […]
